Merkel-cell carcinoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up

被引：2

作者：

Lugowska, I. ^{[1
]}

Becker, J. C. ^{[2
,3
]}

Ascierto, P. A. ^{[4
]}

Veness, M. ^{[5
,6
]}

Blom, A. ^{[7
]}

Lebbe, C. ^{[8
,9
,10
]}

Migliano, E. ^{[11
]}

Hamming-Vrieze, O. ^{[12
]}

Goebeler, M. ^{[13
]}

Kneitz, H. ^{[13
]}

Nathan, P. ^{[14
]}

Rutkowski, P. ^{[15
]}

Slowinska, M. ^{[16
]}

Schadendorf, D. ^{[17
,18
,19
,20
]}

Piulats, J. M. ^{[21
]}

Petrelli, F. ^{[22
]}

van Akkooi, A. C. J. ^{[23
,24
,25
]}

Berruti, A. ^{[26
]}

机构：

[1] Mar Sklodowska Curie Natl Res Inst Oncol, Dept Early Phase Clin Trials, Warsaw, Poland

[2] Univ Hosp Essen, Dept Translat Skin Canc Res, German Canc Consortium DKTK, Essen, Germany

[3] Deutsch Krebsforsch Zentrum DKFZ, Dept Translat Skin Canc Res, Heidelberg, Germany

[4] Ist Nazl Tumori IRCCS Fdn G Pascale, Dept Melanoma Canc Immunotherapy & Dev Therapeut, Naples, Italy

[5] Univ Sydney, Sydney Med Sch, Sydney, Australia

[6] Westmead Hosp, Dept Radiat Oncol, Sydney, Australia

[7] UVSQ, Univ Paris Saclay, Ambroise Pare Hosp,CARADERM Network, AP HP,EA4340 BECCOH,Dept Gen & Oncol Dermatol, Boulogne, France

[8] Univ Paris Cite, Paris, France

[9] Hop St Louis, AP HP, Dermatooncol & CIC Dept, Paris, France

[10] INSERM U976, Paris, France

[11] San Gallicano Dermatol Inst IRCCS, Dept Plast & Regenerat Surg, Rome, Italy

[12] Netherlands Canc Inst Antoni van Leeuwenhoek, Dept Radiat Oncol, Amsterdam, Netherlands

[13] Univ Hosp Wurzburg, Dept Dermatol Venereol & Allergol, Wurzburg, Germany

[14] Mt Vernon Canc Ctr, Dept Med Oncol, Northwood, England

[15] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Soft Tissue Bone Sarcoma & Melanoma, Warsaw, Poland

[16] Natl Res Inst, Mil Inst Med, Dept Dermatol, Warsaw, Poland

[17] Univ Hosp Essen, Dept Dermatol, Westdeutsch Tumorzentrum WTZ, Essen, Germany

[18] German Canc Consortium DKTK, Partner Site Essen, Essen, Germany

[19] NCT West Campus Essen, Essen, Germany

[20] Univ Alliance Ruhr, Res Ctr One Hlth, Essen, Germany

[21] Univ Barcelona, Inst Catala Oncol ICO, Inst Invest Biomed Bellvitge IDIBELL, Med Oncol Dept,CIBEROnc, Barcelona, Spain

[22] Azienda Socio Sanit Terr ASST Bergamo Oves, Oncol Unit, Treviglio, Italy

[23] Melanoma Inst Australia, Dept Melanoma & Surg Oncol, Sydney, Australia

[24] Univ Sydney, Fac Med & Hlth, Sydney, Australia

[25] Royal Prince Alfred Hosp, Dept Melanoma & Surg Oncol, Sydney, Australia

[26] Univ Brescia, Dept Med & Surg Specialties, Med Oncol Unit, Radiol Sci & Publ Hlth,ASST Spedali Civili, Brescia, Italy

[27] ESMO Guidelines Comm, ESMO Head Off, Via Ginevra 4, CH-6900 Lugano, Switzerland

来源：

ESMO OPEN | 2024年 / 9卷 / 05期

关键词：

clinical practice guideline; diagnosis; follow-up; Merkel-cell carcinoma; treatment recommendation; MOHS MICROGRAPHIC SURGERY; RADIATION-THERAPY; PROGNOSTIC-FACTORS; POLYOMAVIRUS INFECTION; ADJUVANT RADIOTHERAPY; RARE CANCERS; NODE BIOPSY; OPEN-LABEL; T-ANTIGEN; SURVIVAL;

D O I：

10.1016/j.esmoop.2024.102977

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页数：14

共 50 条

[31] Merkel-cell carcinoma: a follow up study
Borbola, K.
Plotar, V
Eles, K.
Liszkay, G.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 117 - 117
[32] Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Haanen, J.
Obeid, M.
Spain, L.
Carbonnel, F.
Wang, Y.
Robert, C.
Lyon, A. R.
Wick, W.
Kostine, M.
Peters, S.
Jordan, K.
Larkin, J.
ANNALS OF ONCOLOGY, 2022, 33 (12) : 1217 - 1238
[33] Renal cell carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
Escudier, B.
Kataja, V.
ANNALS OF ONCOLOGY, 2009, 20 : 81 - 82
[34] Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
Gronchi, A.
Miah, A. B.
DeiTos, A. P.
Abecassis, N.
Bajpai, J.
Bauer, S.
Biagini, R.
Bielack, S.
Blay, J. Y.
Bolle, S.
Bonvalot, S.
Boukovinas, I
Bovee, J. V. M. G.
Boye, K.
Brennan, B.
Brodowicz, T.
Buonadonna, A.
De Alava, E.
Del Muro, X. G.
Dufresne, A.
Eriksson, M.
Fagioli, F.
Fedenko, A.
Ferraresi, V
Ferrari, A.
Frezza, A. M.
Gasperoni, S.
Gelderblom, H.
Gouin, F.
Grignani, G.
Haas, R.
Hassan, A. B.
Hecker-Nolting, S.
Hindi, N.
Hohenberger, P.
Joensuu, H.
Jones, R. L.
Jungels, C.
Jutte, P.
Kager, L.
Kasper, B.
Kawai, A.
Kopeckova, K.
Krakorova, D. A.
Le Cesne, A.
LeGrange, F.
Legius, E.
Leithner, A.
Lopez-Pousa, A.
Martin-Broto, J.
ANNALS OF ONCOLOGY, 2021, 32 (11) : 1348 - 1365
[35] Melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Dummer, R.
Hauschild, A.
Guggenheim, M.
Jost, L.
Pentheroudakis, G.
ANNALS OF ONCOLOGY, 2010, 21 : v194 - v197
[36] Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up
Kusamura, S.
Kepenekian, V
Villeneuve, L.
Lurvink, R. J.
Govaerts, K.
De Hingh, I. H. J. T.
Moran, B. J.
Van der Speeten, K.
Deraco, M.
Glehen, O.
EJSO, 2021, 47 (01): : 36 - 59
[37] Endometrial carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
Baekelandt, M. M.
Castiglione, M.
ANNALS OF ONCOLOGY, 2008, 19 : 19 - 20
[38] Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Verslype, C.
Rosmorduc, O.
Rougier, P.
ANNALS OF ONCOLOGY, 2012, 23 : 41 - 48
[39] Hepatocellular carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
Parikh, P.
Malhotra, H.
Jelic, S.
ANNALS OF ONCOLOGY, 2008, 19 : 27 - 28
[40] Hepatocellular carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
Jelic, S.
ANNALS OF ONCOLOGY, 2009, 20 : 41 - 45

← 1 2 3 4 5 →